Frank C. Detterbeck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Frank C. Detterbeck has a total of 535 co-authors. Here are the top co-authors by number of shared publications:
Hisao Asamura
Division of Thoracic Surgery, Keio School of Medicine, Tokyo, Japan
12 shared publicationsAndrew G. Nicholson
Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas NHS Foundation, Trust and National Heart and Lung Institute, Imperial College, London, UK
11 shared publicationsKazuya Kondo
10 shared publicationsLynn T. Tanoue
Division of Pulmonary Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut
10 shared publicationsMeinoshin Okumura
10 shared publications- Conrad Falkson
Kingston Health Sciences Center, Kingston, ON K7L 2V7, Canada
9 shared publications
Latest Publications
- 27 September 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 27 (2) , 237-241
Striving for an Enhanced Tumor Classification System: Reflections on Cancer, Prognosis, Human Nature and Reality
- 27 September 2025
- Published by Elsevier in Clinical Lung Cancer
- Vol. 27 (2) , 237-241
Striving for an Enhanced Tumor Classification System: Reflections on Cancer, Prognosis, Human Nature and Reality
- 1 September 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (11) , 110425
Classification of recurrence patterns in surgically treated non-small cell lung cancer – A systematic review and a call for standardization
- 1 September 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (11) , 110425
Classification of recurrence patterns in surgically treated non-small cell lung cancer – A systematic review and a call for standardization
- Open Access
- 22 July 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (10) , 7108-7111
Updates on the Version 9 American Joint Committee on Cancer Staging System for Thymic Malignancies
- 22 July 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (10) , 7108-7111
Open AccessUpdates on the Version 9 American Joint Committee on Cancer Staging System for Thymic Malignancies
- 9 July 2025
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 46 (05) , 419-427
Lung Cancer with Cystic Airspace: An Overview
There is increased recognition that some lung cancers arise from or are associated with air-filled cystic spaces. Recognition of precursors is important because these are often overlooked and because some of these cancers progress rapidly once a solid component develops. A systematic review suggests that such precursors typically appear as irregular air cysts; these should be distinguished from bullae and smooth round cysts with paper-thin walls that are often seen incidentally with increasing age. Such irregular cysts usually enlarge slowly before developing a ground glass or small solid component or becoming multiloculated. Such change warrants careful surveillance; continued progression of a solid component justifies intervention. Early intervention is associated with good outcomes; survival markedly diminishes if resection occurs when a more substantial solid component has developed.
- 9 July 2025
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 46 (05) , 419-427
Lung Cancer with Cystic Airspace: An Overview
There is increased recognition that some lung cancers arise from or are associated with air-filled cystic spaces. Recognition of precursors is important because these are often overlooked and because some of these cancers progress rapidly once a solid component develops. A systematic review suggests that such precursors typically appear as irregular air cysts; these should be distinguished from bullae and smooth round cysts with paper-thin walls that are often seen incidentally with increasing age. Such irregular cysts usually enlarge slowly before developing a ground glass or small solid component or becoming multiloculated. Such change warrants careful surveillance; continued progression of a solid component justifies intervention. Early intervention is associated with good outcomes; survival markedly diminishes if resection occurs when a more substantial solid component has developed.
- 14 December 2024
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 20 (5) , 597-613
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor Classification for Lung Cancer—Results from an International Survey Among Pathologists and Thoracic Surgeons
- 14 December 2024
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 20 (5) , 597-613
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor Classification for Lung Cancer—Results from an International Survey Among Pathologists and Thoracic Surgeons
- 6 December 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 169 (3) , 787-795.e2
Does thymectomy in adults have long-term health consequences?
- 6 December 2024
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 169 (3) , 787-795.e2
Does thymectomy in adults have long-term health consequences?
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Mediastinum
- Vol. 8, AB042
AB042. Deep dive into the NEJM study suggesting health consequences after thymectomy
Background: A recent study raised questions about health consequences of thymectomy in adults. International Thymic Malignancy Interest Group (ITMIG) members need a thorough understanding of this. Methods: The study hypothesis was that thymectomy leads to worse survival and increased subsequent cancer, autoimmune disease, and infection (due to immune compromise). The primary analysis compared patients undergoing thymectomy to matched controls undergoing cardiac surgery, with endpoints of survival, subsequent cancer, autoimmune disease, or infection. The secondary analysis aimed to correlate the primary findings with an increase in severity of subsequent cancers—by analyzing unmatched patient subsets (n=75) who developed cancer or autoimmune disease after thymectomy vs. cardiac surgery. A tertiary analysis assessed immune function markers in an unmatched subset in whom blood was available (n=19/22). Results: The primary analysis suggested that thymectomy was associated with worse survival and more cancers, but not autoimmune disease or infection. However, confidence in interpretation and attribution of the effect to thymectomy is weakened by questions regarding the comparator selection, matching process, the approach to confirmatory subset analyses and the time period when differences became manifest. The secondary analysis suggests that thymectomy is associated with more aggressive cancers and multiplicity of autoimmune diseases than the comparator cohort. However, the thymectomy and cardiac surgery cohorts were unmatched; differences in age and sex and ambiguities regarding endpoint definitions create uncertainly in interpretation and effect attribution. Interpretation of the tertiary analysis is hampered by the limited cohort of unmatched patients; however, evidence of diminished immune function was seen after thymectomy vs. controls, and in patients who developed cancer vs. those who didn’t. Conclusions: The NEJM study suggested that thymectomy may have health consequences, which is consistent with basic science data (reviewed separately) that immune compromise associated with thymic involution may be linked to the incidence of cancer, autoimmune disease and infections with increasing age. However, the questions regarding the structure of the NEJM study as discussed in this abstract leave uncertainties how clearly the observations can be attributed to thymectomy.
- 1 December 2024
- Published by AME Publishing Company in Mediastinum
- Vol. 8, AB042
Open AccessAB042. Deep dive into the NEJM study suggesting health consequences after thymectomy
Background: A recent study raised questions about health consequences of thymectomy in adults. International Thymic Malignancy Interest Group (ITMIG) members need a thorough understanding of this. Methods: The study hypothesis was that thymectomy leads to worse survival and increased subsequent cancer, autoimmune disease, and infection (due to immune compromise). The primary analysis compared patients undergoing thymectomy to matched controls undergoing cardiac surgery, with endpoints of survival, subsequent cancer, autoimmune disease, or infection. The secondary analysis aimed to correlate the primary findings with an increase in severity of subsequent cancers—by analyzing unmatched patient subsets (n=75) who developed cancer or autoimmune disease after thymectomy vs. cardiac surgery. A tertiary analysis assessed immune function markers in an unmatched subset in whom blood was available (n=19/22). Results: The primary analysis suggested that thymectomy was associated with worse survival and more cancers, but not autoimmune disease or infection. However, confidence in interpretation and attribution of the effect to thymectomy is weakened by questions regarding the comparator selection, matching process, the approach to confirmatory subset analyses and the time period when differences became manifest. The secondary analysis suggests that thymectomy is associated with more aggressive cancers and multiplicity of autoimmune diseases than the comparator cohort. However, the thymectomy and cardiac surgery cohorts were unmatched; differences in age and sex and ambiguities regarding endpoint definitions create uncertainly in interpretation and effect attribution. Interpretation of the tertiary analysis is hampered by the limited cohort of unmatched patients; however, evidence of diminished immune function was seen after thymectomy vs. controls, and in patients who developed cancer vs. those who didn’t. Conclusions: The NEJM study suggested that thymectomy may have health consequences, which is consistent with basic science data (reviewed separately) that immune compromise associated with thymic involution may be linked to the incidence of cancer, autoimmune disease and infections with increasing age. However, the questions regarding the structure of the NEJM study as discussed in this abstract leave uncertainties how clearly the observations can be attributed to thymectomy.
- 20 September 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (5) , 967-979
Anesthetic Risk with Large Mediastinal Masses: A Management Framework Based on a Systematic Review
- 20 September 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 119 (5) , 967-979
Anesthetic Risk with Large Mediastinal Masses: A Management Framework Based on a Systematic Review
- Top Cited Papers
The Proposed Ninth Edition TNM Classification of Lung Cancer